Fidelity’s FMR LLC Discloses 2.39M AMN Shares, 6.2% Ownership

Rhea-AI Filing Summary

FMR LLC and its chair & CEO Abigail P. Johnson have filed a Schedule 13G disclosing a 6.2 % passive stake in AMN Healthcare Services, Inc. (AMN) as of 30 Jun 2025. The position equals 2,391,522.85 common shares.

• Sole voting power: 2,388,349 shares
• Sole dispositive power: 2,391,522.85 shares
• Shared voting/dispositive power: 0 shares

The filing is made under Rule 13d-1(b) by a parent holding company/control person. An affiliated fund, Fidelity Small Cap Value Fund, holds 1,980,849 shares (5.2 %) within the aggregate amount. The signatory certifies the stake is held in the ordinary course of business without intent to influence control.

While no purchase history or cost basis is provided, FMR’s >5 % ownership signals continued institutional interest in AMN. No other material events, financial results, or strategic actions are disclosed.

Positive

• Institutional validation: A respected asset manager now holds 6.2 % of AMN’s outstanding shares, potentially enhancing market confidence and liquidity.

Negative

• None.

Insights

Financial Analyst

TL;DR – FMR discloses 6.2 % passive stake; neutral to mildly supportive signal.

FMR LLC, a major institutional investor, now controls 2.39 m AMN shares. Passive 13G status indicates no activist agenda, but Fidelity’s exposure may enhance liquidity and lend confidence to smaller-cap AMN. The stake size is material yet not dominant, limiting governance influence. Market impact is typically modest unless accumulated rapidly, which the filing does not quantify. Overall, it is a routine ownership update rather than a catalyst.

Corporate Governance Specialist

TL;DR – Ownership crosses 5 % threshold; no control intent stated.

Because the filing is on Schedule 13G, FMR pledges a passive stance, reducing the likelihood of proxy initiatives. Voting power remains solely with FMR, but at 6.2 % the block is insufficient to sway outcomes without broader support. Disclosure complies with Section 13(d) and includes subsidiary identification under Rule 13d-1(k). Governance risk is unchanged; board composition and strategy remain issuer-controlled.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AMN HEALTHCARE SVCS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

001744101

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 001744101

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,388,349.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,391,522.85
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,391,522.85

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.2 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 001744101

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,391,522.85
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,391,522.85

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.2 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AMN HEALTHCARE SVCS INC
(b)	Address of issuer's principal executive offices: 2999 Olympus Boulevard,Suite 500,Dallas,TX,US,75019
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 001744101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2391522.85
(b)	Percent of class: 6.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 2391522.85
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of AMN HEALTHCARE SVCS INC. The interest of Fidelity Small Cap Value Fund, in the COMMON STOCK of AMN HEALTHCARE SVCS INC, amounted to 1980849.00 shares or 5.2% of the total outstanding COMMON STOCK at 06/30/2025.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	08/05/2025

Abigail P. Johnson

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
Date:	08/05/2025

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

How many AMN shares does FMR LLC own?

FMR reports ownership of 2,391,522.85 common shares.

What percentage of AMN Healthcare does this stake represent?

The disclosed position equals 6.2 % of the outstanding common stock.

Is FMR’s filing activist or passive?

It is passive; the Schedule 13G certification states no intent to influence control.

Which Fidelity fund holds a large portion of the stake?

Fidelity Small Cap Value Fund holds 1,980,849 shares, or 5.2 % of AMN stock.

When was the event triggering this filing?

Ownership crossed the 5 % threshold on 30 June 2025.